EyePoint Inc (STU:PV3B)
€ 11.3 -0.70 (-5.83%) Market Cap: 960.04 Mil Enterprise Value: 782.38 Mil PE Ratio: 0 PB Ratio: 4.72 GF Score: 41/100

EyePoint Inc at Goldman Sachs Healthcare Conference Transcript

Jun 9, 2026 / 03:20 PM GMT
Release Date Price: €10.1 (+2.54%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EYPT.OQ - EyePoint Inc
EyePoint Inc at Goldman Sachs Healthcare Conference
Jun 09, 2026 / 03:20PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
First, welcome to Jay Ducker and George Elston from iPoint Pharmaceuticals here at the 47th Annual Goldman Sachs Healthcare Conference. Welcome, gentlemen.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you very much.

--------------------------------------------------------------------------------
Unidentified_1 [3]
--------------------------------------------------------------------------------
For those in the audience and listening who may be newer to the story, can you start at a high level?

Overview of iPoint today, core clinical
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot